Oncology Emergencies Flashcards

1
Q

Red flags for cancer

A

 Age > 50 (single most important risk factor) or < 17
 Previous history of cancer
 Night pain or pain at rest
 Unexplained weight loss
 Family history (1st generation)
 Environment and lifestyle
 Failure to improve as expected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Red flags for cancer recurrence

A
  • Positive lymph nodes
  • Tumor size > 2cm
  • High grade histopathologic
    designation
  • Can reoccur at same location, in local lymph nodes, in distant
    lymph nodes, or in metastatic sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most Common tumors that metastasize to bone

A

Breast
Lung
Thyroid
Kidney
Prostate
Multiple Myeloma
Melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is myelosuppresion

A
  • Common side effect associated with nearly all chemotherapy and immunosuppressive agents
  • Inhibition of bone marrow cells resulting in fewer red cells, white cells, and/or platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does myelosuppresion often result in?

A

anemia, infection, and bleeding as a result of a reduced number of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anemia

A
  • A pathologic state resulting in a reduction of the oxygen carrying capacity of the blood
  • Not a disease, rather a symptom of many other diseases
  • Frequent complication of cancer treatment especially chemotherapy and radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hemoglobin reference values

A

 Norms
 Male: 14-17.4 g/dL
 Female: 12-16 g/dL
 Anemia: <11 g/dL
 Severe anemia: <8 g/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anemia Rehab Implications

A
  • Aerobic capacity is increased with higher levels of hemoglobin
  • Worsening anemia reduces exercise tolerance and endurance
  • Precautions should be used in prescribing progressive resistance and moderate to
    high intensity aerobic exercise in individuals with severe anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rehab implications for hemoglobin less than 11 g/dL

A

establish baseline vital signs; may be tachycardic or present
with orthostatic hypertension; symptom-based approach to intervention, monitoring
self-perceived exertion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rehab implication for severe anemia

A

close monitoring of symptoms and vital signs with interventions; transfusion may or may not be indicated based on individual presentation; short periods of intervention, symptom-limited; education for energy conservation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is thrombocytopenia

A

decrease in platelet count below 150,000 of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

causes of thrombocytopenia

A

 Inadequate platelet production from bone marrow
 Increased platelet destruction outside the bone marrow
 Splenic sequestration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

< 150,000 thrombocytopenia

A

Symptoms based approach; monitor tolerance to activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

150,000 - 50,000 platelet count

A

Progressive exercise tolerated; aerobic and resistive with monitoring for symptoms associated with bleeding; swimming; low bench stepping; bicycling (flat only, no grade); manual muscle testing could be performed without restriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

20,000 to 50,000 platelet count

A

Active range of motion exercises; moderate activity; light weights;
stationary bicycle; walking as tolerated; no prolonged stretching; aquatic therapy based on immune status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

10,000 to 20,000 platelet count

A

Light exercise; no resistive training or activity; avoid Valsalva; AROM exercise only; walking as tolerated, guard carefully; assess fall risk, implement safety plan for falls prevention; understand transfusion status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

< 10,000 platelet count

A

Restricted to ADLs; walking with MD approval; dependent upon individual risk factors and characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Neutrophils

A

Target bacterial and fungus
General Phagocytosis
45-75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lymphocytes

A
  • Produce antibodies
  • B cells, T cells, natural killer cells
  • 20-40%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Eosinophins

A
  • target large parasites and modulate allergic inflammatory responses
    1-4%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Monocytes

A

Largest WBC
Phagocytosis of large parasites
2-8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Basophils

A

Release heparin and histamine during an allergic reaction
0.5-1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Neutropenia

A
  • A condition associated with a reduction in circulating neutrophils or absolute neutrophil count (ANC)
  • Typically, the result of toxicity to neutrophil precursors in the bone marrow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is neutropenia associated with?

A

 Carcinoma
 Malignant hematopoietic disorders that can lead to pancytopenia (reduction in ALL
blood cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

mild neutropenia

A

1,000 - 1,500

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

moderate neutropenia

A

500 - 1,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

severe neutropenia

A

< 500

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Profound neutropenia

A

< 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

ANC Nadir

A
  • Chemotherapy induced neutropenia
     Point when the ANC is at its lowest after chemotherapy treatment
     Typically, 3-10 days after the administration of the chemotherapeutic agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What does ANC Nadir cause?

A
  • Increased susceptibility to infection
     Typical signs and symptoms of infection are often absent in neutropenia
     Fever remains the earliest sign of occult infection
     Primary sites of infection: GI tract, sinuses, lungs, and skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is one of the most common complications related to cancer treatment?

A
  • Neutropenic Fever
    80% of people for hematologic malignancy
    10-50% with solid tumor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is neutropenic fever defined as?

A
  • A single oral or axillary temperature of > 101 degrees F
    OR
  • A temperature > 100.4 degrees F sustained over 60 minutes in a patient with ANC <500
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Is PT contraindicated with neutropenic fever?

A

NOPE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Rehab implications for neutropenic fever

A
  • Proceed with treatment based on facility guidelines
     Special consideration should be given if the patient is experiencing Fatigue, Malaise, Dizziness, Lethargy
  • PT should monitor at-risk individuals for early signs and symptoms of infection –> expedite medical management * Practice good hand hygiene with antimicrobial products during every patient encounter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is tumor lysis syndrome

A
  • Collection of metabolic disorders that result from the death of neoplastic cells which
    then release their intracellular contents into the circulation = metabolic crisis that can lead to death
  • Most commonly seen in patients with very aggressive hematologic cancers
    ** can be fatal if not addressed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

When does tumor lysis syndrome occur?

A
  • Occurs after effective therapy is initiated or spontaneously (cytotoxic chemotherapy, glucocorticoid therapy, endocrine therapy,
    radiotherapy)
     Most commonly as a result of chemotherapy
  • Typically presents within 7 days of cancer treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Tumor Lysis syndrome clinical presentation

A

 Fatigue, signs of dehydration, seizures, cardiac arrythmias, nausea and
vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Key lab findings in tumor lysis syndrome

A
  • hyperkalemia (most immediate threat)
  • hyperuricemia
  • hyperphosphatemia (leads to hypocalcemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What can kyperuricemia lead to

A

acute kidney injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

hyperphosphatemia

A

 Phosphate binds with calcium to form calcium phosphate crystals leading to
hypocalcemia
 Leads to anorexia, vomiting, seizures, or cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

tumor lysis syndrome rehab implications

A
  • Patient’s may complain of muscle weakness, spasm, and/or cramping
  • ↑ uric acid –> arthralgias and renal colic
     Paresthesia and paralysis (hyperkalemia)
     Seizures, tetany, lethargy (hyperphosphatemia)
     Lethargy, malaise, sleepiness, seizures (hyperuricemia)
     Paresthesia, tetany, confusion, delirium, hallucinations (hypocalcemia)
    *** type of pain you get with kidney stones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What should you monitor for in tumor lysis syndrome

A

 CV effects during activity: arrythmias, abnormal changes in BP, tachycardia
 Volume overload: dyspnea, pulmonary crackles, edema, HTN
 GI: anorexia, nausea, vomiting, diarrhea, hyperactive bowel sounds, abdominal pain, bloating or cramps

43
Q

What can electrolyte imbalances trigger?

A

clotting cascade, leading to
disseminated intravascular coagulation

44
Q

Tumor lysis syndrome in the ICU setting

A

early progressive mobility and rehabilitation interventions improve recovery and maintain functional status after discharge

45
Q

Hypercalcemia of Malignancy

A
  • Abnormalities in calcium homeostasis –> during active malignancy, late effect due malignancy, or treatment for it
  • Poor prognosis – median survival ~35 days from diagnosis
46
Q

Signs and Symptoms of hypercalcemia of malignancy

A
  • Vague and Diffuse
     Lethargy, fatigue, malaise, bone pain, muscle weakness, anorexia, nausea and vomiting, constipation, polyuria, decline in mental function, confusion, delirium, coma
47
Q

Rehab implications of Hypercalcemia of Malignancy

A

 Assess and ascertain mental status changes and impact on safety judgement
 Mild-to-moderate conditions –> weight bearing activities, general aerobic conditioning, consider assistive device for safety with ambulation
 Sever conditions –> individuals are relatively unresponsive

48
Q

Most common cause of Superior Vena Cava Syndrome

A
  • Thoracic malignant disorders
49
Q

What is Superior Vena Cava Syndrome?

A

Extrinsic compression or occlusion of the superior vena cava

50
Q

Symptoms of Superior Vena Cava Syndrome

A

 Common: dyspnea, orthopnea, cough, sensation of fullness in head and face, and headache, often exacerbated by stooping
 Less common: chest pain, hemoptysis, hoarseness, dizziness, light-headedness, and even syncope

51
Q

Physical findings of Superior Vena Cava Syndrome

A

 Facial and neck swelling, arm swelling, and dilated veins in the chest, neck, and
proximal part of the arms
 Stridor –> indicate laryngeal edema
 Mental status changes = worrisome –> increased intracranial pressure

52
Q

Rehab implications Superior Vena Cava Syndrome

A

 Symptom recognition and observance of change over time will support differential
diagnosis
 Avoid Valsalva maneuvers with activity and exercise
 Heart rate response to activity may be impaired –> Use RPE as a more sensitive self-reported measure during activity

53
Q

Pericardial Effusion

A

excess fluid between the heart and pericardium

54
Q

Malignant Pericardial Effusions

A
  • Commonly seen in patients with advanced and
    metastatic disease
     Related to malignancy OR secondary to radiation therapy
    OR manifestation of infection or autoimmune process
  • Overall prognosis is poor – median survival 130-140 days
55
Q

Presenting symptoms of Malignant Pericardial Effusions

A

 Small effusions: often asymptomatic, do not require urgent therapy
 Large effusion: if rapidly accumulating, can impair ventricular filling and
reduce cardiac output

56
Q

Signs and Symptoms of Malignant Pericardial Effusions

A

 Dyspnea, cough, chest pain, heart palpitations, cyanosis, tachycardia, hypotension, distant heart sounds, fixed jugular distension, peripheral
edema, engorged neck veins, pulsus paradoxus
 Pulsus paradoxus: abnormally large decrease in stroke volume, systolic BP and
pulse wave amplitude during inspiration; drop in BP is >10 mmHg

57
Q

How are Malignant Pericardial Effusions diagnosed?

A

Echocardiography

58
Q

Treatment of Malignant Pericardial Effusions

A

 Pericardiocentesis
 Surgical procedures or instillation of sclerosing agent may be used

59
Q

Rehab Implications of Malignant Pericardial Effusion

A

 Frequent assessment of heart rate, hemodynamic status and respiratory status,
including oximetry levels, should be carried out during treatment
 Assessment of skin color and temperature, capillary refill, and peripheral pulses should be tracked
 Awareness of mental status changes, confusion, or seizures is necessary due to
reduced cerebral blood flow
 After a cardiac tamponade, patients should have medical clearance before re- engaging in rehab care
 Rehabilitation is indicated to provide strengthening and reconditioning activities, pulmonary hygiene, and postural positioning

60
Q

Cancer Related Pain

A
  • One of the most common symptoms associated with cancer
  • Defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in relation to such damage
  • One of the symptoms that patients fear most
61
Q

Cancer related pain is a multifactorial process that may include….

A

 Direct tumor infiltration/involvement
 Unintended damage from diagnostic or therapeutic
surgical procedures (e.g. biopsies, resection)
 Side effects related to cancer therapies (e.g. chemotherapy, radiation therapy)

62
Q

Causes of cancer related pain

A

 Pressure on or displacement of nerves
 Microscopic infiltration of nerves by tumor cells
 Ischemic pain
 Bone metastases

63
Q

Pathophysiologic Classification of Cancer related pain includes…

A

differentiating between pain
associated with the tumor, pain associated with treatment, and pain unrelated to either

64
Q

2 Basic types of cancer related pain

A

 Nociceptive: Results from activation of nociceptors after injury to visceral or
somatic structures
 Neuropathic –> Injury to the peripheral or central nervous system

65
Q

What does visceral pain arise from

A

internal organs and surrounding tissue

66
Q

what are common causes of visceral pain

A

compression, infiltration, or dissension of abdominal and thoracic viscera

67
Q

What is visceral pain described as?

A

diffuse, vague, deep, burning, aching, gnawing, cramping or
crushing

68
Q

Visceral Pain referral

A

May be referred and/or located in dermatomes and myotomes supplied by the neurons that project from the same segments or share the same spinal cord segment as the viscera being affected

69
Q

Visceral Pain treatment

A

 Pharmacologic
 Manual therapy
 Interventional
 Complementary alternative medicine techniques
 Psychosocial support –> integral part of treatment

70
Q

Somatic Pain

A
  • Arises from activation of nociceptive neurons in the skin or musculoskeletal
    tissues (bone, joint, muscle, `connective tissue)
  • Common causes include metastases in the bone and pain related to surgery
  • Skin, bone, joint, muscle and connective tissues
  • Sharp, well-localized, throbbing, pressure-like
71
Q

What is the most common cause of bone pain?

A
  • Tumor involvement of the bone
     Metastasis MUST be considered in the differential diagnosis of patients with
    history of cancer reporting bone pain
     Pain is a warning sign but does not always precede a pathologic fracture
72
Q

Bone metastases are initially

A

asymptomatic

73
Q

common features of bone metastases over time =

A

pain, loss of function, hypercalcemia, and depression –> ↓ in QOL and performance status

74
Q

Common sites for bone metastases

A

 Axial skeleton
 Femur
 Pelvis
 Humerus
 Ribs
 Skull
** vone lesions are typically not solitary

75
Q

What is the single best predictor of pathological fracture

A

functional pain

76
Q

Osteoblastic bone metastasis

A
  • Cancer cells activate osteoblasts increasing deposition of new bone and increasing numbers of irregular bone trabeculae
  • Results in dense, sclerotic/hardening of bones
  • Prostate cancer
77
Q

Osteolytic bone metastasis

A
  • Cancer cells cause excessive breakdown of bone
  • Results in weak, easily breakable bone
  • Multiple Myeloma
78
Q

Mixed type bone metastasis

A
  • Both osteolytic and osteoblastic lesions present or both types are present in the same lesion
  • breast cancer
79
Q

Nonsurgical management of bone metastases

A
  • Pain relief
  • Halt progression of metastatic lesion
  • Prevent fractures
  • Maintaining/restoring mobility
80
Q

Surgical Management of bone metastases

A
  • stabilization for pathologic and/or impending fractures
  • relief of intractable bone pain
  • maintain/restoring mobility
81
Q

Rehab implications and activity considerations for bone metastases

A
  • Optimize function
  • Assistive devices (walker/crutches to unweight; cane for pain control)
  • Isometric strengthening
  • Low-impact conditioning activities
  • Compensatory techniques (e.g., adaptive equipment to minimize bending)
  • Avoidance of high-impact, high torque actions
  • Fall prevention strategies
  • Patient and caregiver education
82
Q

Neuropathic pain

A
  • Injury to the peripheral or central nervous system
  • Burning, sharp, or shooting; often accompanied by numbness or tingling in extremities
  • Tends to be more resistant to treatment with conventional pain- relieving medications
83
Q

causes of neuropathic pain

A

 Tumor compressing or infiltrating the nerves or spinal cord
 Damage to nervous system caused by cancer treatment

84
Q

2 types of neuropathic pain

A

polyneuropathy or peripheral neuropathy
 Longest nerves are most vulnerable, especially to the hands and feet
 Produces a stocking and glove pattern of involvement

85
Q

small diameter sensory nerve fibers

A

 Symptoms of pain or temperature perception loss, dysesthesia, and temperature
misperception
 Signs include cold, hairless, dry, thinner skin

86
Q

Large diameter sensory nerve fibers

A

 Loss of vibration sense/proprioception, numbness, loss of fine touch, imbalance, sensory ataxia (when severe)

87
Q

What is chemotherapy-induced peripheral neuropathy

A
  • Damage to the peripheral nervous system that results from administration of neurotoxic chemotherapeutic
    agents (Taxanes, Platinums, and Vinca alkaloids)
  • Risk of neurotoxicity increases with higher individual and cumulative doses, higher infusion rate and
    coadministration of other neurotoxic agents
88
Q

Dose limiting vs dose-dependent CIPN

A

 Dose-limiting: side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level
of that treatment
 Dose-dependent: side effects change when the dose of the drug is changed

89
Q

What is typical in CIPN

A

sensory abnormalities and neuropathic pain in hands and feet

90
Q

Screening for CIPN

A

 Pattern of presentation, timing of symptom onset, and progression of symptoms –>
helpful in differentiating CIPN from other impairments
 Thorough history is important: Identify if the patient has received any drugs associated with CIPN –> further screening warranted

91
Q

Most common subjective complaints in CIPN

A

 Numbness and/or tingling of toes and fingers
 If weakness is present = symmetrical distal weakness
 Proximal weakness = indicative of steroid-induced myopathy
 Unilateral weakness = indicative of central or peripheral nerve impairment
 PAIN in hands and feet

92
Q

Questionnaire for CIPN

A

Neuropathic Pain (DN4) Questionnaire
> 4/10 indicates neuropathic pain

93
Q

CIPN Treatment

A
  • Few PT intervention studies
  • Education on strategies to increase safety with daily activities –> Decreased touch thresholds which put them at risk for tissue injury
  • Infrared treatment for neuropathic pain
  • Collaboration with medical team to work towards management of neuropathic pain
  • Strength, power, balance training, postural re-education, orthotics
  • Task specific training to improve hand function
94
Q

Malignant Spinal Cord Compression

A
  • Secondary to metastases to vertebral bodies –> collapse or
    compression of vertebral body
  • MEDICAL EMERGENCY as it can lead to permanent. paralysis if treatment is delayed by even a few hours
  • Compression of the cord –> edema, vascular congestion,
    and demyelination
  • Thoracic spine is most commonly involved followed by lumbar and cervical
95
Q

Presenting symptoms of Malignant spinal cord

A

 Pain = 1st sign
– Nociceptive or neuropathic (radicular pain)
– High intensity (8/10)
– Worsens with supine positioning, at night, and with increased thoracic pressure during sneezing, coughing, or straining
 Motor weakness = 2nd sign
– More common than sensory deficits
– Below the area of spinal involvement
– Gait disturbance

96
Q

Treatment for malignant spinal cord compression

A

radiation therapy or surgical

97
Q

radiation therapy for MSCC

A

 Mainstay of treatment
 Goal: relieve compression of the spine and nerve roots –> pain relief and improving/stabilizing the neuro deficit

98
Q

Surgical treatment of MSCC

A

 Decompressive surgical procedure
 Diagnostic by providing a biopsy or stabilize an unstable spine
 May be the only option when there is compression of the cord by bony fragments
following collapse

99
Q

MSCC rehabilitation implications

A

 Pain – worse in recumbent position, at night and with straining
 Thoracic, lumbar, cervical  Limb weakness, difficulty walking
 Signs of nerve root compression
* After surgical decompression and/or radiation therapy, treat the impairments as needed

100
Q

5 A’s of Pain Management

A

 Analgesia: optimize analgesia (pain relief)
 Activities: optimize ADL’s
 Adverse effects: minimize adverse effects
 Aberrant drug-taking: avoid aberrant drug taking (addiction-related outcomes)
 Affect: relationship between pain and mood

101
Q

What should you screen for at every visit?

A

pain and fatigue

102
Q

pain assessment

A
  • Perform a detailed history and physical examination –> Always ask if there is a history of past primary cancer
  • Comprehensive evaluation of pain is essential for proper management
  • Patients who have an oncology diagnosis should be
    screened for pain on every visit
  • If pain is present on any given visit, the pain intensity MUST be quantified by the patient
103
Q

Pain Assessment Tools

A
  • Numeric Pain Rating Scale
  • Visual Analog Scale
  • Pictorial Scale
  • Categorical pain scales
  • Brief Pain Inventory
104
Q

Brief Pain Inventory

A

 Patient reported functional outcome measure
 Assesses pain severity in patients with cancer in 2 domains: Intensity of pain and Pain interference
 Quantifies the measure using a 0 to 10 rating scale